Humedix said Thursday that its single-shot formulation Humia for osteoarthritis has obtained Conformite Europeenne certification, and the company would speed up marketing the new medicine in global markets.According to the company, osteoarthritis patients have only need to take one Humia shot per si
Hanmi Pharmaceutical’s Amozaltan XQ, the world's first four-ingredient combination drug for hypertension and dyslipidemia, received positive reviews from medical specialists at an online conference hosted by the Korean Society of Hypertension.“More than half of hypertension patients have dyslipidemi
To develop a globally competitive homegrown blockbuster drug, Korean pharmaceutical companies should choose the most prominent pipelines and concentrate on them, experts said.The Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) held a press webinar on the pharmaceutical and biot
The U.S. FDA recently approved Janssen’s Rybrevant (ingredient: amivantamab) as the first targeted therapy for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) exon 20 insertion mutations.In Korea, researchers are testing a combination therapy mixing Rybrevant
Daewoong Pharmaceutical said Wednesday that the Indonesian government has promised to provide full support for the Korean drugmaker’s various projects in the Southeast Asian country.Indonesian Minister of Maritime and Investment Affairs Luhut Binsar Pandjaitan and Minister of Health Budi Gunadi Sadi
inno.N will accelerate the research of new anticancer drugs using big data at the National Cancer Center Cancer and Jeonbuk National University Hospital.The company said Wednesday that it plans to use the CONNECT platform, a cancer big data library, to classify target patients, develop biomarkers, s
Biogen is taking a bold step to win U.S. FDA approval for Alzheimer’s treatment candidate aducanumab in June.On Thursday, Biogen announced that its manufacturing facility in Solothurn, Switzerland received a Good Manufacturing Practice (GMP) certification from the Swiss Agency for Therapeutic Produc
Kangstem Biotech, a stem cell therapy provider, plans to develop the world's first stem cell treatment that fundamentally treats atopic dermatitis with a single dose."We received approval for new phase 3 clinical trials for FureStem AD from the Ministry of Food and Drug Safety in May and will start
Bayer’s Xarelto (ingredient: rivaroxaban) has reduced the risk of death of non-valvular atrial fibrillation (NVAF) patients with type 2 diabetes by about 10 percent, as well as their hospitalization caused by bleeding, compared with Warfarin.The company conducted studies from November 2011 to Decemb
Raon Pharma said it would sell the “cheapest hair loss treatment,” heating up price competition in the hair loss prescription drug market.On Monday, Raon Pharma said it would roll out Finaon Tab. 1mg (finasteride). The announcement came 10 months after the launch of Finawin Tab. 1mg (finasteride). B
Janssen Korea said Monday that Cherry Huang has been appointed as its new chief executive officer effective June 1.Huang will double as Janssen's North Asian head by managing its branches in Taiwan and Hong Kong, it said.New CEO Huang, who joined Janssen in 1998, has held various positions in Jansse
Cheong Wa Dae and the ruling Democratic Party of Korea have praised Samsung Biologics' deal with Moderna to manufacture the latter's mRNA Covid-19 in Korea as a huge success.However, experts showed more cautious reactions to the deal and other vaccine-related agreements.Some industry officials and h
Novo Nordisk said Monday that its type-2 diabetes treatment Xultophy has shown superior efficacy in reducing Hemoglobin A1c (HbA1c) level, weight change, and the hypoglycemia events with a lower dose in phase 3 clinical trials.Kangbuk Samsung Hospital Professor Lee Eun-jeong and Seoul National Unive
Daewoong Pharmaceutical said that the U.S. Food and Drug Administration has granted orphan drug designation (ODD) for DWN12088 that treats systemic scleroderma.The designation comes after the drug won an ODD status to treat idiopathic pulmonary fibrosis (IPF) in August 2019.Systemic scleroderma is a
Institut Pasteur Korea (IPK) said Friday that it has agreed to team up with Institut Pasteur to form a global research unit, Ai3D, for image-based profiling of new drug discovery and development using artificial intelligence.The international research team aims to develop next-generation new drug te
The greater Seoul area has been experiencing a shortage of Tylenol since the health authorities announced that people should take Tylenol (ingredient: acetaminophen) when they have a fever after receiving the Covid-19 vaccine."It seems okay to take fever reducers such as Tylenol if you start develop
Pfizer Korea said that it has confirmed improved efficacy and safety of Vizimpro, its epidermal growth factor receptor (EGFR) mutation treatment for non-small cell lung cancer (NSCLC), on Asian patients, including Koreans.The company conducted a subgroup analysis of its ARCHER 1050 phase 3 clinical
MSD’s antidiabetic drug Steglatro (ingredient: ertugliflozin), a sodium-glucose cotransporter 2 (SGLT-2) inhibitor, demonstrated clinical benefits in renal functions, a study said.The results enhance evidence that SGLT-2 inhibitors could be beneficial in kidney disease.An exploratory analysis of the
International Vaccine Institute (IVI) Director-General Jerome Kim said Wednesday that Korea could be a hub for making Covid-19 vaccines in Asia.Kim said that Korean biopharmaceutical companies have the capability to begin manufacturing Covid-19 vaccines within nine months, pointing out that the glob
Pirfenidone, a treatment for idiopathic pulmonary fibrosis with its original drug’s patent expired, showed a remarkable therapeutic effect in heart failure with preserved ejection fraction (HFpEF), a study showed.The study drew much attention because researchers have failed to develop an HFpEF treat